Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2002-11-13
2010-12-28
Ford, Vanessa L (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C424S278100, C530S350000
Reexamination Certificate
active
07858103
ABSTRACT:
A method for defining, identifying and isolating recombinantly produced protein complex is provided. The protein complex comprises a group of fatty acid and retinol-binding proteins wherein the complex protein structure is entirely alpha-helical. The molecular weight of the recombinant protein is approximately 46 kDa comprised of 26 kDa GST and 20 kDa Hp20 protein. The procedures for extracting, isolating and analyzing the recombinantly in vivo produced protein complex and Hp20 protein of the recombinantly in vivo produced protein complex are provided.
REFERENCES:
NCBI AAK57805 http://www.ncbi.nlm.nih.gov/protein/14289131; accessed 2009.
NCBI AAK57805-revision history http://www.ncbi.nlm.nih.gov/entrez/sutils/girevhist.cgi?val=AAK57805&log$=seqview; accessed 2009.
Hoselton et al. (Parasite Immunology, 2002; 24: 429-435).
Tang et al. (International Journal for Parasitology, 1995; 25(7): 847-851 and 858).
Campbell Nelson Whipps LLC
Ford Vanessa L
Tongue Lakia J
LandOfFree
Method for defining, identifying and isolating fatty acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for defining, identifying and isolating fatty acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for defining, identifying and isolating fatty acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4157857